Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 163 entries
Sorted by: Best Match Show Resources per page
Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5.

Frontiers in cell and developmental biology

Forgham H, Johnson D, Carter N, Veuger S, Carr-Wilkinson J.
PMID: 26697427
Front Cell Dev Biol. 2015 Dec 02;3:77. doi: 10.3389/fcell.2015.00077. eCollection 2015.

The prognostic value of cancer stem cell markers in various cancer subtypes is a well documented research area. Our findings show that the stem cell marker Lgr5 is associated with an aggressive phenotype in neuroblastoma. Here, we discuss these...

Cite
Forgham H, Johnson D, Carter N, et al. Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5. Front Cell Dev Biol. 2015;3:77doi: 10.3389/fcell.2015.00077.
Forgham, H., Johnson, D., Carter, N., Veuger, S., & Carr-Wilkinson, J. (2015). Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5. Frontiers in cell and developmental biology, 377. https://doi.org/10.3389/fcell.2015.00077
Forgham, Helen, et al. "Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5." Frontiers in cell and developmental biology vol. 3 (2015): 77. doi: https://doi.org/10.3389/fcell.2015.00077
Forgham H, Johnson D, Carter N, Veuger S, Carr-Wilkinson J. Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5. Front Cell Dev Biol. 2015 Dec 02;3:77. doi: 10.3389/fcell.2015.00077. eCollection 2015. PMID: 26697427; PMCID: PMC4667032.
Copy Download .nbib Format: NLM
Metal borohydride formation from aluminium boride and metal hydrides.

Physical chemistry chemical physics : PCCP

Møller KT, Fogh AS, Paskevicius M, Skibsted J, Jensen TR.
PMID: 27722466
Phys Chem Chem Phys. 2016 Oct 05;18(39):27545-27553. doi: 10.1039/c6cp05391b.

Metal borides are often decomposition products from metal borohydrides and thus play a role in the reverse reaction where hydrogen is absorbed. In this work, aluminium boride, AlB

Cite
Møller KT, Fogh AS, Paskevicius M, et al. Metal borohydride formation from aluminium boride and metal hydrides. Phys Chem Chem Phys. 2016;18(39):27545-27553doi: 10.1039/c6cp05391b.
Møller, K. T., Fogh, A. S., Paskevicius, M., Skibsted, J., & Jensen, T. R. (2016). Metal borohydride formation from aluminium boride and metal hydrides. Physical chemistry chemical physics : PCCP, 18(39), 27545-27553. https://doi.org/10.1039/c6cp05391b
Møller, Kasper T, et al. "Metal borohydride formation from aluminium boride and metal hydrides." Physical chemistry chemical physics : PCCP vol. 18,39 (2016): 27545-27553. doi: https://doi.org/10.1039/c6cp05391b
Møller KT, Fogh AS, Paskevicius M, Skibsted J, Jensen TR. Metal borohydride formation from aluminium boride and metal hydrides. Phys Chem Chem Phys. 2016 Oct 05;18(39):27545-27553. doi: 10.1039/c6cp05391b. PMID: 27722466.
Copy Download .nbib Format: NLM
Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel.

Hormone molecular biology and clinical investigation

Stanczyk FZ, Rubin A, Flood L, Foegh M.
PMID: 25961260
Horm Mol Biol Clin Investig. 2011 May 01;6(2):231-40. doi: 10.1515/HMBCI.2011.004.

BACKGROUND: The only available contraceptive patch, Ortho Evra®, delivers a relatively high dose of estrogen.MATERIALS AND METHODS: Three transdermal contraceptive delivery systems (TCDS) containing low doses of ethinylestradiol (EE) and levonorgestrel (LNG) were evaluated in two open-label randomized trials....

Cite
Stanczyk FZ, Rubin A, Flood L, et al. Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel. Horm Mol Biol Clin Investig. 2011;6(2):231-40doi: 10.1515/HMBCI.2011.004.
Stanczyk, F. Z., Rubin, A., Flood, L., & Foegh, M. (2011). Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel. Hormone molecular biology and clinical investigation, 6(2), 231-40. https://doi.org/10.1515/HMBCI.2011.004
Stanczyk, Frank Z, et al. "Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel." Hormone molecular biology and clinical investigation vol. 6,2 (2011): 231-40. doi: https://doi.org/10.1515/HMBCI.2011.004
Stanczyk FZ, Rubin A, Flood L, Foegh M. Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel. Horm Mol Biol Clin Investig. 2011 May 01;6(2):231-40. doi: 10.1515/HMBCI.2011.004. PMID: 25961260.
Copy Download .nbib Format: NLM
A quantitative evaluation of medication histories and reconciliation by discipline.

Hospital pharmacy

Kramer JS, Stewart MR, Fogg SM, Schminke BC, Zackula RE, Nester TM, Eidem LA, Rosendale JC, Ragan RH, Bond JA, Goertzen KW.
PMID: 25477614
Hosp Pharm. 2014 Oct;49(9):826-38. doi: 10.1310/hpj4909-826.

BACKGROUND/OBJECTIVE: Medication reconciliation at transitions of care decreases medication errors, hospitalizations, and adverse drug events. We compared inpatient medication histories and reconciliation across disciplines and evaluated the nature of discrepancies.METHODS: We conducted a prospective cohort study of patients admitted...

Cite
Kramer JS, Stewart MR, Fogg SM, et al. A quantitative evaluation of medication histories and reconciliation by discipline. Hosp Pharm. 2014;49(9):826-38doi: 10.1310/hpj4909-826.
Kramer, J. S., Stewart, M. R., Fogg, S. M., Schminke, B. C., Zackula, R. E., Nester, T. M., Eidem, L. A., Rosendale, J. C., Ragan, R. H., Bond, J. A., & Goertzen, K. W. (2014). A quantitative evaluation of medication histories and reconciliation by discipline. Hospital pharmacy, 49(9), 826-38. https://doi.org/10.1310/hpj4909-826
Kramer, Joan S, et al. "A quantitative evaluation of medication histories and reconciliation by discipline." Hospital pharmacy vol. 49,9 (2014): 826-38. doi: https://doi.org/10.1310/hpj4909-826
Kramer JS, Stewart MR, Fogg SM, Schminke BC, Zackula RE, Nester TM, Eidem LA, Rosendale JC, Ragan RH, Bond JA, Goertzen KW. A quantitative evaluation of medication histories and reconciliation by discipline. Hosp Pharm. 2014 Oct;49(9):826-38. doi: 10.1310/hpj4909-826. PMID: 25477614; PMCID: PMC4252186.
Copy Download .nbib Format: NLM
Masking of iron with fluoride in the extractive atomic-absorption spectrometric determination of chromium in steel.

Talanta

Fogg AG, Soleymanloo S, Burns DT.
PMID: 18961681
Talanta. 1975 Jun;22(6):541-3. doi: 10.1016/0039-9140(75)80050-6.

Chromium in steel is determined by oxidation to dichromate, extraction into methyl isobutyl ketone from 1-3 M hydrochloric acid, and atomic-absorption measurements on the extract. The interference of iron in the atomic absorption is eliminated by using fluoride to...

Cite
Fogg AG, Soleymanloo S, Burns DT. Masking of iron with fluoride in the extractive atomic-absorption spectrometric determination of chromium in steel. Talanta. 1975;22(6):541-3doi: 10.1016/0039-9140(75)80050-6.
Fogg, A. G., Soleymanloo, S., & Burns, D. T. (1975). Masking of iron with fluoride in the extractive atomic-absorption spectrometric determination of chromium in steel. Talanta, 22(6), 541-3. https://doi.org/10.1016/0039-9140(75)80050-6
Fogg, A G, et al. "Masking of iron with fluoride in the extractive atomic-absorption spectrometric determination of chromium in steel." Talanta vol. 22,6 (1975): 541-3. doi: https://doi.org/10.1016/0039-9140(75)80050-6
Fogg AG, Soleymanloo S, Burns DT. Masking of iron with fluoride in the extractive atomic-absorption spectrometric determination of chromium in steel. Talanta. 1975 Jun;22(6):541-3. doi: 10.1016/0039-9140(75)80050-6. PMID: 18961681.
Copy Download .nbib Format: NLM
Visible spectrophotometric determination of cephalosporins and penicillins by indophenol derivatization with and without alkaline degradation to ammonia.

Journal of pharmaceutical and biomedical analysis

Fogg AG, Abdalla MA.
PMID: 16867666
J Pharm Biomed Anal. 1985;3(4):315-21. doi: 10.1016/0731-7085(85)80038-8.

Cephalosporins and penicillins give reproducible yields of ammonia on degradation in 0.5 M sodium hydroxide solution at 100 degrees C: the ammonia formed was determined in the degraded solutions using the indophenol reaction. In another approach the ammonia driven...

Cite
Fogg AG, Abdalla MA. Visible spectrophotometric determination of cephalosporins and penicillins by indophenol derivatization with and without alkaline degradation to ammonia. J Pharm Biomed Anal. 1985;3(4):315-21doi: 10.1016/0731-7085(85)80038-8.
Fogg, A. G., & Abdalla, M. A. (1985). Visible spectrophotometric determination of cephalosporins and penicillins by indophenol derivatization with and without alkaline degradation to ammonia. Journal of pharmaceutical and biomedical analysis, 3(4), 315-21. https://doi.org/10.1016/0731-7085(85)80038-8
Fogg, A G, and Abdalla, M A. "Visible spectrophotometric determination of cephalosporins and penicillins by indophenol derivatization with and without alkaline degradation to ammonia." Journal of pharmaceutical and biomedical analysis vol. 3,4 (1985): 315-21. doi: https://doi.org/10.1016/0731-7085(85)80038-8
Fogg AG, Abdalla MA. Visible spectrophotometric determination of cephalosporins and penicillins by indophenol derivatization with and without alkaline degradation to ammonia. J Pharm Biomed Anal. 1985;3(4):315-21. doi: 10.1016/0731-7085(85)80038-8. PMID: 16867666.
Copy Download .nbib Format: NLM
Cathodic stripping voltammetric determination at a hanging mercury drop electrode of the environmental heavy metal precipitant trimercapto-s-triazine (TMT).

Talanta

Fogg AG, Ismail R, Yusoff AR, Ahmad R, Banica FG.
PMID: 18966768
Talanta. 1997 Mar;44(3):497-500. doi: 10.1016/s0039-9140(96)02073-5.

Trimercapto-s-triazine (TMT) is available commercially for precipitating heavy metals in effluents prior to discharge and for recovering silver and copper. The TMT content of an effluent for discharge is normally monitored down to about 2 ppm by means of...

Cite
Fogg AG, Ismail R, Yusoff AR, et al. Cathodic stripping voltammetric determination at a hanging mercury drop electrode of the environmental heavy metal precipitant trimercapto-s-triazine (TMT). Talanta. 1997;44(3):497-500doi: 10.1016/s0039-9140(96)02073-5.
Fogg, A. G., Ismail, R., Yusoff, A. R., Ahmad, R., & Banica, F. G. (1997). Cathodic stripping voltammetric determination at a hanging mercury drop electrode of the environmental heavy metal precipitant trimercapto-s-triazine (TMT). Talanta, 44(3), 497-500. https://doi.org/10.1016/s0039-9140(96)02073-5
Fogg, A G, et al. "Cathodic stripping voltammetric determination at a hanging mercury drop electrode of the environmental heavy metal precipitant trimercapto-s-triazine (TMT)." Talanta vol. 44,3 (1997): 497-500. doi: https://doi.org/10.1016/s0039-9140(96)02073-5
Fogg AG, Ismail R, Yusoff AR, Ahmad R, Banica FG. Cathodic stripping voltammetric determination at a hanging mercury drop electrode of the environmental heavy metal precipitant trimercapto-s-triazine (TMT). Talanta. 1997 Mar;44(3):497-500. doi: 10.1016/s0039-9140(96)02073-5. PMID: 18966768.
Copy Download .nbib Format: NLM
Hexacyanoferrate(III) as a mediator in the determination of total iron in potable waters as iron(II)-1,10-phenanthroline at a single-use screen-printed carbon sensor device.

Talanta

Jezek J, Dilleen JW, Haggett BG, Fogg AG, Birch BJ.
PMID: 19071289
Talanta. 2007 Jan 15;71(1):202-7. doi: 10.1016/j.talanta.2006.03.051. Epub 2006 May 12.

Hexacyanoferrate(III) was used as a mediator in the determination of total iron, as iron(II)-1,10-phenanthroline, at a screen-printed carbon sensor device. Pre-reduction of iron(III) at -0.2V versus Ag/AgCl (1M KCl) in the presence of hexacyanoferrate(II) and 1,10-phenanthroline (pH 3.5-4.5), to...

Cite
Jezek J, Dilleen JW, Haggett BG, et al. Hexacyanoferrate(III) as a mediator in the determination of total iron in potable waters as iron(II)-1,10-phenanthroline at a single-use screen-printed carbon sensor device. Talanta. 2006;71(1):202-7doi: 10.1016/j.talanta.2006.03.051.
Jezek, J., Dilleen, J. W., Haggett, B. G., Fogg, A. G., & Birch, B. J. (2007). Hexacyanoferrate(III) as a mediator in the determination of total iron in potable waters as iron(II)-1,10-phenanthroline at a single-use screen-printed carbon sensor device. Talanta, 71(1), 202-7. https://doi.org/10.1016/j.talanta.2006.03.051
Jezek, Jan, et al. "Hexacyanoferrate(III) as a mediator in the determination of total iron in potable waters as iron(II)-1,10-phenanthroline at a single-use screen-printed carbon sensor device." Talanta vol. 71,1 (2007): 202-7. doi: https://doi.org/10.1016/j.talanta.2006.03.051
Jezek J, Dilleen JW, Haggett BG, Fogg AG, Birch BJ. Hexacyanoferrate(III) as a mediator in the determination of total iron in potable waters as iron(II)-1,10-phenanthroline at a single-use screen-printed carbon sensor device. Talanta. 2007 Jan 15;71(1):202-7. doi: 10.1016/j.talanta.2006.03.051. Epub 2006 May 12. PMID: 19071289.
Copy Download .nbib Format: NLM
Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Osiri M, Saag KG, Ford AM, Moreland LW.
PMID: 19078458
J Clin Rheumatol. 2000 Jun;6(3):117-22. doi: 10.1097/00124743-200006000-00001.

Osteoporosis is a serious side effect of long-term glucocorticoid (GC) use, but there is little success at prevention. We sought to identify academic physicians' awareness of glucocorticoid-induced osteoporosis (GIOP) risk and the patient and provider characteristics that determine GIOP...

Cite
Osiri M, Saag KG, Ford AM, et al. Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. J Clin Rheumatol. 2000;6(3):117-22doi: 10.1097/00124743-200006000-00001.
Osiri, M., Saag, K. G., Ford, A. M., & Moreland, L. W. (2000). Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 6(3), 117-22. https://doi.org/10.1097/00124743-200006000-00001
Osiri, M, et al. "Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 6,3 (2000): 117-22. doi: https://doi.org/10.1097/00124743-200006000-00001
Osiri M, Saag KG, Ford AM, Moreland LW. Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. J Clin Rheumatol. 2000 Jun;6(3):117-22. doi: 10.1097/00124743-200006000-00001. PMID: 19078458.
Copy Download .nbib Format: NLM
Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis.

Nephron extra

Takagi N, Tanizawa T, Kon V, Fogo AB, Ichikawa I, Ma J.
PMID: 22479265
Nephron Extra. 2012 Jan;2(1):17-26. doi: 10.1159/000334961. Epub 2012 Jan 31.

BACKGROUND: We previously showed that angiotensin type 1 receptor (AT1) blocker (ARB) attenuates glomerular injury in Nphs1-hCD25 (NEP25) transgenic mice, a model of selective podocyte injury. However, subsequent studies in NEP25 mice with podocyte-specific deficiency of AT1 revealed that...

Cite
Takagi N, Tanizawa T, Kon V, et al. Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron Extra. 2012;2(1):17-26doi: 10.1159/000334961.
Takagi, N., Tanizawa, T., Kon, V., Fogo, A. B., Ichikawa, I., & Ma, J. (2012). Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron extra, 2(1), 17-26. https://doi.org/10.1159/000334961
Takagi, Nobuaki, et al. "Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis." Nephron extra vol. 2,1 (2012): 17-26. doi: https://doi.org/10.1159/000334961
Takagi N, Tanizawa T, Kon V, Fogo AB, Ichikawa I, Ma J. Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron Extra. 2012 Jan;2(1):17-26. doi: 10.1159/000334961. Epub 2012 Jan 31. PMID: 22479265; PMCID: PMC3318935.
Copy Download .nbib Format: NLM
Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation.

Thrombosis journal

Jerath MR, Liu P, Struthers M, Demartino JA, Peng R, Peterson LB, Cumiskey AM, Yang L, Rojas M, Patel DD, Fong AM.
PMID: 20836883
Thromb J. 2010 Sep 13;8:14. doi: 10.1186/1477-9560-8-14.

OBJECTIVES: The chemokine receptors CCR2 and CX3CR1 are important in the development of coronary artery disease. The purpose of this study is to analyze the effect of a novel CCR2 inhibitor in conjunction with CX3CR1 deletion on vascular inflammation.METHODS:...

Cite
Jerath MR, Liu P, Struthers M, et al. Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation. Thromb J. 2010;8:14doi: 10.1186/1477-9560-8-14.
Jerath, M. R., Liu, P., Struthers, M., Demartino, J. A., Peng, R., Peterson, L. B., Cumiskey, A. M., Yang, L., Rojas, M., Patel, D. D., & Fong, A. M. (2010). Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation. Thrombosis journal, 814. https://doi.org/10.1186/1477-9560-8-14
Jerath, Maya R, et al. "Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation." Thrombosis journal vol. 8 (2010): 14. doi: https://doi.org/10.1186/1477-9560-8-14
Jerath MR, Liu P, Struthers M, Demartino JA, Peng R, Peterson LB, Cumiskey AM, Yang L, Rojas M, Patel DD, Fong AM. Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation. Thromb J. 2010 Sep 13;8:14. doi: 10.1186/1477-9560-8-14. PMID: 20836883; PMCID: PMC3161339.
Copy Download .nbib Format: NLM
Structure and magnetism of the A site scandium perovskite (Sc0.94Mn0.06)Mn0.65Ni0.35O3 synthesized at high pressure.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Thomas CI, Suchomel MR, Duong GV, Fogg AM, Claridge JB, Rosseinsky MJ.
PMID: 24615150
Philos Trans A Math Phys Eng Sci. 2014 Mar 10;372(2013):20130012. doi: 10.1098/rsta.2013.0012. Print 2014 Apr 13.

Scandium perovskite (Sc0.94Mn0.06)Mn0.65Ni0.35O3, synthesized at high pressure and high temperature, has a triclinic structure (space group ) at room temperature and ambient pressure with a √2ap×√2ap×2ap structure with α≈90(°),β≈89(°),γ≈90(°). Magnetic measurements show that the material displays Curie-Weiss behaviour above...

Cite
Thomas CI, Suchomel MR, Duong GV, et al. Structure and magnetism of the A site scandium perovskite (Sc0.94Mn0.06)Mn0.65Ni0.35O3 synthesized at high pressure. Philos Trans A Math Phys Eng Sci. 2014;372(2013):20130012doi: 10.1098/rsta.2013.0012.
Thomas, C. I., Suchomel, M. R., Duong, G. V., Fogg, A. M., Claridge, J. B., & Rosseinsky, M. J. (2014). Structure and magnetism of the A site scandium perovskite (Sc0.94Mn0.06)Mn0.65Ni0.35O3 synthesized at high pressure. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 372(2013), 20130012. https://doi.org/10.1098/rsta.2013.0012
Thomas, Chris I, et al. "Structure and magnetism of the A site scandium perovskite (Sc0.94Mn0.06)Mn0.65Ni0.35O3 synthesized at high pressure." Philosophical transactions. Series A, Mathematical, physical, and engineering sciences vol. 372,2013 (2014): 20130012. doi: https://doi.org/10.1098/rsta.2013.0012
Thomas CI, Suchomel MR, Duong GV, Fogg AM, Claridge JB, Rosseinsky MJ. Structure and magnetism of the A site scandium perovskite (Sc0.94Mn0.06)Mn0.65Ni0.35O3 synthesized at high pressure. Philos Trans A Math Phys Eng Sci. 2014 Mar 10;372(2013):20130012. doi: 10.1098/rsta.2013.0012. Print 2014 Apr 13. PMID: 24615150.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 163 entries